Mainstream

Biomarin raises 2025 full year guidance with $3.125b revenue target and advances bmn 333

BioMarin raises 2025 full-year guidance with $3.125B revenue target and advances BMN 333

BioMarin raises 2025 full-year guidance with $3.125B revenue target and advances BMN 333

Post ContentbmrnRead More

You might also be interested in reading SEC Proposes Capital Offering Reforms To Support Smaller Corporate Issuers.

August 5, 2025
In Mainstream